#Finland #Tampere #Annual General Meeting #Bioretec Ltd #Financial Statements

Notice of Annual General Meeting for Bioretec Ltd

Bioretec Ltd has officially announced its Annual General Meeting (AGM) set for March 21, 2025. This event will take place at 11:00 AM Finnish time at their headquarters in Tampere, located at Yrittäjänkulma 5, FI-33710. All registered shareholders are urged to attend, whether in person or through a proxy representative. It is critical for shareholders wishing to participate to register by March 11, 2025, at 4:00 PM Finnish time, with detailed instructions listed below.

Participation Guidelines

Shareholders can join the AGM and exercise their rights through a proxy, which requires presenting a dated power of attorney. The registration can be done via email, phone, or mail, as specified below:

• - Email: [email protected]
• - Phone: +358 20 778 9500
• - Mail: Bioretec Ltd, Yrittäjänkulma 5, FI-33710 Tampere

When registering, shareholders must provide their name, identification number, contact details, and the name of any assistant or proxy.

Agenda for the AGM

The agenda for the upcoming meeting includes crucial discussions and decisions. Here are the highlights:
1. Opening of the meeting
2. Election of officials to scrutinize minutes and supervise vote counting
3. Review of the financial statements and board report for 2024
4. Proposal to approve the financial statements, noting a loss of EUR 4,669,883.08 for the period
5. Setting of board member remuneration and a vote on the discharge from liability for the board and CEO
6. Election of board members, with proposed candidates and their qualifications presented in advance on the company website
7. Review and approval of the auditor’s compensation and election of PricewaterhouseCoopers Oy as the auditor until 2026
8. Authorization of the board to issue shares and special rights
9. Discussion on amendments to the Articles of Association to allow hybrid or remote meeting formats
10. Closing of the meeting

Financial Performance Overview

During the AGM, shareholders will particularly focus on the financial performance of Bioretec Ltd for the financial year ending December 31, 2024. The board will present the financial statements, auditor's report, and a review by the CEO. Shareholders will also vote on the proposed financial measures, including the decision to retain earnings rather than distributing dividends due to the noted loss.

The board of directors has further recommended remuneration adjustments, proposing monthly compensation for board members, including a suggested EUR 3,750 per month for the chairperson and EUR 2,000 per month for regular members. This adjustment reflects the company's strategic focus on rewarding members who contribute to Bioretec's growth and governance.

Board Elections

A significant part of the agenda is the election of new board members, with the shareholders’ nomination board proposing names of candidates with strong backgrounds in business and health sciences. This includes re-elections and new candidates aimed at enhancing the board’s effectiveness and diversity.

Additional Information

The detailed agenda, including individual board member presentations, will be made available on the company’s official website at Bioretec AGM 2025.

Bioretec encourages all eligible shareholders to participate actively in shaping the company’s future. This meeting not only serves as a platform for important financial decisions but also allows for valuable networking and collaboration among stakeholders.

A reminder for shareholders: to ensure your right to participate in the AGM and that your voice is heard, please complete your registration by the specified deadline, and prepare any questions you may have regarding the agenda items.

Tampere, Finland, February 28, 2025, Bioretec Ltd, Board of Directors.